Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease.
Bahdoudi, Seyma
Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease. [electronic resource] - Cellular and molecular life sciences : CMLS 06 2018 - 2075-2091 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1420-9071
10.1007/s00018-017-2727-2 doi
Animals
Diazepam Binding Inhibitor--therapeutic use
Disease Models, Animal
Dopaminergic Neurons--drug effects
Gene Expression Regulation--drug effects
Humans
Male
Mice, Inbred C57BL
Neuropeptides--therapeutic use
Neuroprotective Agents--therapeutic use
Oxidative Stress--drug effects
Parkinson Disease--drug therapy
Peptide Fragments--therapeutic use
Reactive Oxygen Species--metabolism
Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease. [electronic resource] - Cellular and molecular life sciences : CMLS 06 2018 - 2075-2091 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1420-9071
10.1007/s00018-017-2727-2 doi
Animals
Diazepam Binding Inhibitor--therapeutic use
Disease Models, Animal
Dopaminergic Neurons--drug effects
Gene Expression Regulation--drug effects
Humans
Male
Mice, Inbred C57BL
Neuropeptides--therapeutic use
Neuroprotective Agents--therapeutic use
Oxidative Stress--drug effects
Parkinson Disease--drug therapy
Peptide Fragments--therapeutic use
Reactive Oxygen Species--metabolism